RE:RE:RE:Shareholder letterThe covid serology test will be bringing in money well before the AD test. The one thing I personally learned from the letter, was that the company was first going to develope an AD test for the use of others that are developing products associated to amyloid science . Once that is done the company would go onto to complete the test that was specfic to PMN310. Give covid projects till end of this month. They must have stumbled onto something with all the talk about a possible vaccine .. you dont normally cover that topic unless you have a found previously unknown hidden gem in your rock pile.